Loading live market data…

Intellia Therapeutics, Inc.

NASDAQ:NTLA

$13.04 USD

-$0.26 (-1.95%)

Volume
3.92M
Average Volume
6.91M
Market Capitalization
$1.46B
P/E Ratio
-3.68
Dividend Yield
0.00%
Price Target
$25.00
Year High
$28.25
Year Low
$7.95
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$6.10

NTLA Estimated and Actual Revenue by Quarter

NTLA Estimated and Actual EPS by Quarter

NTLA Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2029-12-31 5 -17.28M -14.35M -16.54M -17.28M -14.35M -16.54M
2029-09-30 5 -14.37M -11.93M -13.76M -14.37M -11.93M -13.76M
2029-06-30 5 -11.07M -9.19M -10.6M -11.07M -9.19M -10.6M
2029-03-31 5 -8.79M -7.3M -8.42M -8.79M -7.3M -8.42M
2028-12-31 4 -6.83M -5.68M -6.54M -6.83M -5.68M -6.54M
2028-09-30 4 -5.62M -4.67M -5.38M -5.62M -4.67M -5.38M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2029-12-31 5 -76.89M -60.17M -72.69M 31.68M 38.15M 36.52M
2029-09-30 5 -76.98M -60.24M -72.78M 26.35M 31.72M 30.37M
2029-06-30 5 -77.28M -60.47M -73.06M 20.29M 24.43M 23.4M
2029-03-31 5 -81.84M -64.04M -77.37M 16.12M 19.41M 18.58M
2028-12-31 4 -48.71M -38.12M -46.05M 12.53M 15.09M 14.45M
2028-09-30 4 -65.27M -51.07M -61.7M 10.3M 12.4M 11.88M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2029-12-31 5 14.35M 17.28M 16.54M 4 -0.64892 -0.50779 -0.6135
2029-09-30 5 11.93M 14.37M 13.76M 4 -0.64966 -0.50837 -0.6142
2029-06-30 5 9.19M 11.07M 10.6M 7 -0.6522 -0.51035 -0.6166
2029-03-31 5 7.3M 8.79M 8.42M 5 -0.6907 -0.54048 -0.653
2028-12-31 4 5.68M 6.83M 6.54M 5 -0.41109 -0.32168 -0.38865
2028-09-30 4 4.67M 5.62M 5.38M 10 -0.55082 -0.43102 -0.52075